Federated Hermes Inc. Sells 7,265 Shares of HCA Healthcare, Inc. $HCA

Federated Hermes Inc. lessened its stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 51.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,984 shares of the company’s stock after selling 7,265 shares during the period. Federated Hermes Inc.’s holdings in HCA Healthcare were worth $2,977,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC bought a new stake in HCA Healthcare during the fourth quarter worth about $1,021,000. NewEdge Advisors LLC lifted its position in HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares during the last quarter. Sivia Capital Partners LLC grew its position in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the last quarter. Janney Montgomery Scott LLC lifted its holdings in shares of HCA Healthcare by 4.5% in the 2nd quarter. Janney Montgomery Scott LLC now owns 14,633 shares of the company’s stock worth $5,606,000 after acquiring an additional 636 shares during the last quarter. Finally, Ameritas Advisory Services LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at $153,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on HCA. Zacks Research cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Cantor Fitzgerald raised their price target on HCA Healthcare from $525.00 to $588.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 28th. Wells Fargo & Company increased their price objective on HCA Healthcare from $452.00 to $481.00 and gave the company an “equal weight” rating in a research note on Friday. Stephens upped their price target on shares of HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Finally, Royal Bank Of Canada boosted their price objective on shares of HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Fifteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $519.71.

Check Out Our Latest Stock Report on HCA Healthcare

HCA Healthcare Price Performance

HCA stock opened at $498.91 on Wednesday. The firm has a 50-day moving average of $480.64 and a 200 day moving average of $440.25. The company has a market cap of $113.85 billion, a P/E ratio of 17.58, a PEG ratio of 1.52 and a beta of 1.36. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $527.55.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter in the prior year, the business earned $6.22 EPS. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is currently 10.15%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

See Also

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.